Europe Bioprocessing Market Forecast to 2031

Europe Bioprocessing Market Forecast to 2031

Europe Bioprocessing Market Forecast to 2031 – Regional Analysis – by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)

Send Enquiry
Item ID: BMIRE00030824 Category: Tag:

$2,485 – $3,885

Description

The Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach US$ 16,803.47 million by 2031; it is estimated to register a CAGR of 13.2% from 2023 to 2031.

Growing Biopharmaceutical Industry Drives Europe Bioprocessing Market

In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.

Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market.

Europe Bioprocessing Market Overview

Biosimilars introduce competition and increase the affordability of biologics, which ultimately deliver savings and value-added services to support patient care and the healthcare industry. Healthcare professionals can treat more patients with high-quality biologics at reduced cost. Due to the massive potential for cost savings, the German Health Ministry introduced a new law to increase the adoption of biosimilars. Also, a growing number of partnerships among international players boost the market growth in the country. For instance, in November 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC and apceth Biopharma GmbH expanded their relationship with Bluebird Bio to enter into long-term development and manufacturing services agreements for clinical and commercial supply of multiple therapies, as well as expand commercial drug product manufacturing capacity in Europe for ZYNTEGLO, a one-time gene therapy for transfusion-dependent ?-thalassemia (TDT). Further, the biotechnology sector in Germany exhibits tremendous growth owing to the presence of numerous biotechnology companies, high-tech research labs, and massive funding for research and development. The growth of research and development in biopharmaceuticals and biologics is majorly driven by the adoption of various organic strategies by companies in the healthcare industry. For instance, in June 2021, Rentschler Biopharma expanded its production capacity with a 2,000-liter bioreactor to address the increasing demand for complex antibodies, a class of biopharmaceutical drugs with continued high potential. Likewise, in August 2023, Sartorius, one of the leading suppliers for the biopharmaceutical industry, collaborated with global technology and software leader Emerson to integrate Sartorius’s Biostat STR Generation 3 family of bioreactors with Emerson’s DeltaVTM distributed control system (DCS). Thus, the biopharmaceutical sector in the country is growing due to increasing R&D expenditure by biopharmaceutical companies. Thus, collaborative research efforts by biopharmaceutical and biotechnology companies in the country influence the market.

Europe Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Europe Bioprocessing Market Segmentation

The Europe bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Europe bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Europe bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Europe bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Europe bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Europe bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Europe bioprocessing market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Europe bioprocessing market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 13.2% CAGR, Europe Bioprocessing Market is Speculated to be Worth US$ 16,803.47 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach US$ 16,803.47 million by 2031, registering a CAGR of 13.2% from 2023 to 2031. Proliferating demand for personalized medicine and growing biopharmaceutical industry are among the critical factors attributed to drive the Europe bioprocessing market growth.

The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products-many of them for a relatively small group of patients. Therefore, a fundamentally different approach to the production and delivery of biological products may be required. Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, which has subsequently boosted the growth of personalized medicines. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to the patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.

On the contrary, stringent regulatory policies and limitations associated with bioprocessing hamper the growth of Europe bioprocessing market.

Based on product, the Europe bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held 67.3% market share in 2023, amassing US$ 4,182.67 million. It is projected to garner US$ 11,709.40 million by 2031 to register 13.7% CAGR during 2023-2031. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors sub segment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the sub segment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Europe bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held 82.0% share of Europe bioprocessing market in 2023, amassing US$ 5,096.84 million. It is anticipated to garner US$ 14,183.83 million by 2031 to expand at 13.6% CAGR during 2023-2031.

By process, the Europe bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess aids segment held 57.1% share of Europe bioprocessing market in 2023, amassing US$ 3,549.90 million. It is projected to garner US$ 9,822.48 million by 2031 to expand at 13.6% CAGR from 2023 to 2031.

Based on application, the Europe bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held 38.3% share of Europe bioprocessing market in 2023, amassing US$ 2,379.11 million. It is predicted to garner US$ 6,015.00 million by 2031 to expand at 12.3% CAGR between 2023 and 2031.

In terms of end user, the Europe bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies held 53.4% share of Europe bioprocessing market in 2023, amassing US$ 3,317.06 million. It is estimated to garner US$ 9,097.63 million by 2031 to expand at 13.4% CAGR during 2023-2031.

By country, the Europe bioprocessing market is segmented into Germany, Italy, the UK, France, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 27.1% share of Europe bioprocessing market in 2023. It was assessed at US$ 1,685.29 million in 2023 and is likely to hit US$ 4,770.50 million by 2031, registering a CAGR of 13.9% during 2023-2031.

Key players operating in the Europe bioprocessing market are Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC, among others.

In August 2023, To combine Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor, Sartorius AG and Repligen launched an integrated bioreactor system. According to both firms, the objective is to make the deployment of N perfusion and intensified seed train easier for biopharmaceutical makers.

In March 2023, Corning Inc and Curia have partnered to develop and expedite continuous-flow manufacturing and development programs for the chemical and biopharmaceutical sectors worldwide. The first installation of Corning’s G1 production system, intended for the continuous industrial manufacture of active pharmaceutical ingredients, is part of Curia with the Advanced-Flow Reactor team at Corning.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocessing market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioprocessing market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Europe Bioprocessing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market – Europe Analysis
6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Europe Bioprocessing Market Analysis – by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
7.2.2.1.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
7.2.2.1.2 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
8. Europe Bioprocessing Market Analysis – by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Bioprocessing Market Analysis – by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10. Europe Bioprocessing Market Analysis – by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11. Europe Bioprocessing Market Analysis – by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12. Europe Bioprocessing Market – Country Analysis
12.1 Europe
12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
12.1.1.3 United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
12.1.1.5 France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
12.1.1.7 Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
12.1.1.9 Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Research Team
15.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
Table 4. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
Table 5. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
Table 6. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
Table 7. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 8. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 9. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 10. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 11. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 12. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 13. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 14. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 15. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 16. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 17. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 18. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 19. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 23. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 24. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 25. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 26. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 27. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 28. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 29. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 30. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 31. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 32. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 33. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 34. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 35. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 36. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 37. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 38. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 39. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 40. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 41. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 42. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 43. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 44. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 45. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 46. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 47. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 48. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 49. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 50. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 51. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 52. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 53. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 54. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 59. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 60. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market

LIST OF FIGURES

Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) – by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) – by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) – by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) – by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) – by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market

The List of Companies – Europe Bioprocessing Market

o Getinge AB
o Thermo Fisher Scientific Inc
o Sartorius AG
o Corning Inc
o Bio-Rad Laboratories Inc
o Merck KGaA
o 3M Co
o Eppendorf SE
o Repligen Corp
o Entegris Inc
o Agilent Technologies Inc
o Cytiva US LLC.

Reviews

There are no reviews yet.

Be the first to review “Europe Bioprocessing Market Forecast to 2031”